RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Abstract

RON (MST1R) is one of two members of the MET receptor tyrosine kinase family, along with parent receptor MET. RON has a putative role in several cancers, but its expression and function is poorly characterized in gastroesophageal adenocarcinoma. A recognized functional role of MET tyrosine kinase in gastroesophageal cancer has led to early phase clinical… (More)
DOI: 10.4161/cbt.12.1.15747

25 Figures and Tables

Topics

  • Presentations referencing similar topics